Last month, the FDA released the latest in a series of agency guidance to advance the development and use of real-world data (RWD) and real-world evidence (RWE) in clinical trial designs for drug development programs. Now more than ever there will be a focus on RWE. In this video, Mordecai Kramer discusses how Carevive Smart Data™ can help Observe RWE.